PELIZZARI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 3.466
AS - Asia 1.385
EU - Europa 746
SA - Sud America 178
AF - Africa 40
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.818
Nazione #
US - Stati Uniti d'America 3.411
SG - Singapore 673
CN - Cina 239
VN - Vietnam 160
BR - Brasile 139
IT - Italia 128
HK - Hong Kong 126
DE - Germania 117
RU - Federazione Russa 85
UA - Ucraina 68
FR - Francia 60
GB - Regno Unito 59
IN - India 54
FI - Finlandia 42
IE - Irlanda 37
CA - Canada 36
BE - Belgio 25
PL - Polonia 21
BD - Bangladesh 18
SE - Svezia 18
TR - Turchia 18
AR - Argentina 15
ES - Italia 15
JP - Giappone 15
NL - Olanda 14
AT - Austria 13
IQ - Iraq 13
MX - Messico 12
ZA - Sudafrica 12
KR - Corea 11
CZ - Repubblica Ceca 9
ID - Indonesia 9
MA - Marocco 8
IR - Iran 7
VE - Venezuela 7
LT - Lituania 6
CO - Colombia 5
HU - Ungheria 5
UZ - Uzbekistan 5
EC - Ecuador 4
EG - Egitto 4
LV - Lettonia 4
PH - Filippine 4
PK - Pakistan 4
RO - Romania 4
SA - Arabia Saudita 4
CL - Cile 3
IL - Israele 3
KE - Kenya 3
LB - Libano 3
TG - Togo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
ET - Etiopia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AU - Australia 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
LY - Libia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 5.818
Città #
Ashburn 420
Singapore 329
Fairfield 262
Chandler 228
San Jose 203
Ann Arbor 138
Hong Kong 124
Beijing 123
Chicago 121
Woodbridge 112
Houston 108
Los Angeles 106
Seattle 103
Wilmington 95
Cambridge 83
Council Bluffs 76
New York 71
Boardman 55
Salt Lake City 46
Lauterbourg 44
Dong Ket 41
Princeton 39
Jacksonville 36
Dublin 35
Munich 35
Dallas 34
Dearborn 34
Hanoi 34
Ho Chi Minh City 31
Buffalo 30
Frankfurt am Main 26
Brussels 25
Helsinki 24
Montreal 23
San Diego 23
Santa Clara 21
Elk Grove Village 20
Warsaw 18
Tampa 17
Redmond 16
Ogden 15
Redondo Beach 15
São Paulo 15
The Dalles 15
Tokyo 15
Izmir 13
Lancaster 13
London 13
Chennai 12
Denver 12
Poplar 12
Udine 12
Washington 12
Milan 11
Turku 11
Brooklyn 10
Des Moines 10
Miami 10
Newark 10
Orem 10
Sterling 10
Hefei 9
Martignacco 9
Düsseldorf 8
Nuremberg 8
Phoenix 8
Seoul 8
Stockholm 8
Toronto 8
Johannesburg 7
Leawood 7
San Francisco 7
Vienna 7
Ardabil 6
Baghdad 6
Biên Hòa 6
Brno 6
Charlotte 6
Da Nang 6
Manchester 6
Pittsburgh 6
Augusta 5
Boston 5
City of London 5
Detroit 5
Dulles 5
Hải Dương 5
Lappeenranta 5
Marseille 5
Mumbai 5
Norwalk 5
Salvador 5
Trieste 5
Amsterdam 4
Belo Horizonte 4
Cairo 4
Caracas 4
Hyderabad 4
Jinan 4
Kansas City 4
Totale 3.895
Nome #
Immunotherapy in NSCLC Patients with Brain Metastases 456
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 217
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 192
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 182
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 181
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 173
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 164
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 153
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 152
Do platinum salts fit all triple negative breast cancers? 151
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 150
Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? 145
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 142
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 142
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 140
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 139
Atezolizumab for the treatment of breast cancer 134
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 133
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients 129
Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle 128
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 127
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 125
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 124
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors 123
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 118
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 113
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic 112
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach 110
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 109
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation 107
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 104
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 100
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 99
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 96
Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies 95
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 91
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 88
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 87
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era 85
Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion 84
Drug holidays and overall survival of patients with metastatic colorectal cancer 78
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: The ERA project 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 11 Medical and Health Sciences 1103 Clinical Sciences 72
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota 70
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase 63
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study 63
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives 60
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA) 60
Totale 5.966
Categoria #
all - tutte 22.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 0 0 84
2021/2022357 26 39 2 7 6 17 24 21 4 51 116 44
2022/2023475 47 57 11 59 57 106 4 36 63 7 20 8
2023/2024295 24 10 18 10 53 101 2 14 21 15 1 26
2024/2025939 25 51 33 59 74 46 75 50 121 78 123 204
2025/20262.522 336 451 113 233 377 196 242 89 178 172 125 10
Totale 5.966